128 related articles for article (PubMed ID: 28562165)
41. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma.
Kim DN; Chae HS; Oh ST; Kang JH; Park CH; Park WS; Takada K; Lee JM; Lee WK; Lee SK
J Virol; 2007 Jan; 81(2):1033-6. PubMed ID: 17079300
[TBL] [Abstract][Full Text] [Related]
42. The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways.
Park GB; Kim D; Kim YS; Kim S; Lee HK; Yang JW; Hur DY
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1770-9. PubMed ID: 24569586
[TBL] [Abstract][Full Text] [Related]
43. E5 and E6/E7 of high-risk HPVs cooperate to enhance cancer progression through EMT initiation.
Al Moustafa AE
Cell Adh Migr; 2015; 9(5):392-3. PubMed ID: 26177717
[TBL] [Abstract][Full Text] [Related]
44. Downregulation of microRNA-200 in EBV-associated gastric carcinoma.
Shinozaki A; Sakatani T; Ushiku T; Hino R; Isogai M; Ishikawa S; Uozaki H; Takada K; Fukayama M
Cancer Res; 2010 Jun; 70(11):4719-27. PubMed ID: 20484038
[TBL] [Abstract][Full Text] [Related]
45. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
46. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
[TBL] [Abstract][Full Text] [Related]
47. Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.
Huang D; Duan H; Huang H; Tong X; Han Y; Ru G; Qu L; Shou C; Zhao Z
Sci Rep; 2016 Feb; 6():20502. PubMed ID: 26846307
[TBL] [Abstract][Full Text] [Related]
48. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
[TBL] [Abstract][Full Text] [Related]
49. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
Kim J; Lee HS; Bae SI; Lee YM; Kim WH
Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
[TBL] [Abstract][Full Text] [Related]
50. Maintenance of the viral episome is essential for the cell survival of an Epstein-Barr virus positive gastric carcinoma cell line.
Oh ST; Kim M; Lee SK
Arch Pharm Res; 2009 May; 32(5):729-36. PubMed ID: 19471888
[TBL] [Abstract][Full Text] [Related]
51. Characterization of Epstein-Barr virus infection in a human signet ring cell gastric carcinoma cell line, HSC-39.
Luo B; Murakami M; Fukuda M; Fujioka A; Yanagihara K; Sairenji T
Microbes Infect; 2004 Apr; 6(5):429-39. PubMed ID: 15109957
[TBL] [Abstract][Full Text] [Related]
52. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
53. [State of art: Epstein Barr virus-associated gastric carcinoma].
Fukayama M; Chong JM; Kaizaki Y; Sakurai S
Nihon Rinsho; 1997 Feb; 55(2):357-62. PubMed ID: 9046823
[TBL] [Abstract][Full Text] [Related]
54. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
[TBL] [Abstract][Full Text] [Related]
55. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.
Kang GH; Lee S; Kim WH; Lee HW; Kim JC; Rhyu MG; Ro JY
Am J Pathol; 2002 Mar; 160(3):787-94. PubMed ID: 11891177
[TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus and gastric carcinoma.
Osato T; Imai S
Semin Cancer Biol; 1996 Aug; 7(4):175-82. PubMed ID: 8946601
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus involvement in gastric cancer: biomarker for lymph node metastasis.
Tokunaga M; Land CE
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):449-50. PubMed ID: 9610796
[TBL] [Abstract][Full Text] [Related]
58. The Gastric Microbiome and Its Influence on Gastric Carcinogenesis: Current Knowledge and Ongoing Research.
Zhang C; Powell SE; Betel D; Shah MA
Hematol Oncol Clin North Am; 2017 Jun; 31(3):389-408. PubMed ID: 28501083
[TBL] [Abstract][Full Text] [Related]
59. Infectious agents and gastric tumours. An increasing role for Epstein-Barr virus.
Mladenova I; Pellicano R
Panminerva Med; 2003 Sep; 45(3):183-8. PubMed ID: 14618116
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus and gastric carcinoma.
Fukayama M
Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
